Onesource Specialty Pharma Limited (ONESOURCE) Share Price
NSE · Healthcare · Biotechnology · ISIN INE013P01021
Key metrics
- Market Cap
- ₹17,570 Cr
- P/E Ratio
- —
- EPS
- -4.29
- Book Value
- 508.74
- P/B Ratio
- 3
- ROE
- -1.27%
- ROCE
- 0.34%
- Debt / Equity
- 0.26
- Net Margin
- -5.19%
- Revenue Growth
- -1.61%
- Profit Growth
- -310.68%
- Dividend Yield
- —
- 52W High
- ₹1,925.00
- 52W Low
- ₹1,057.00
- Market Cap Band
- mid cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Onesource Specialty Pharma Limited
OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; soft gelatin capsules; and biologics solutions for microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and RNA products. The company was formerly known as Stelis Biopharma Limited and changed its name to OneSource Specialty Pharma Limited in February 2024. OneSource Specialty Pharma Limited was incorporated in 2007 and is based in Bengaluru, India.
- Headquarters
- Bengaluru, India
- Promoter Holding
- 35.49%
The full Onesource Specialty Pharma Limited analysis
Create a free account to open the complete ONESOURCE deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.